With his extensive background in medical technology and a deep focus on driving innovation, Faisal Zain has become a leading voice in the application of value-based care to solve some of healthcare’s most persistent challenges. Today, we'll delve into his insights on transforming care for c
Millions of low-income Americans are on the verge of a precarious new reality where maintaining essential health insurance is contingent not on a willingness to work, but on navigating the often-insurmountable barriers of personal illness and family caregiving. This policy shift represents a
The road for patients with advanced hepatocellular carcinoma often narrows dramatically after initial treatments falter, leaving few effective options and a stark prognosis for those who see their disease progress. While the advent of immunotherapy has revolutionized first-line care, a significant
Navigating End-of-Life Choices: The New York Medical Aid in Dying Act A profound shift in the conversation surrounding end-of-life autonomy has arrived in New York, as Governor Kathy Hochul has officially signed the amended Medical Aid in Dying Act into law. This landmark legislation, the result of
I'm joined today by Faisal Zain, a leading expert in U.S. healthcare policy with deep insights into hospital finance and pharmaceutical pricing. We're here to unpack the recent, and for many, welcome decision by the Department of Health and Human Services to scrap its controversial 340B
With a deep background in the manufacturing and innovation of medical technology, Faisal Zain has become a leading voice at the intersection of healthcare and venture capital. He focuses on how startups are leveraging technology to solve some of medicine’s most persistent challenges. Today, we d
